Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PEOPLE - Novel Diagnostics makes appointment:

This article was originally published in Clinica

Executive Summary

Infectious diseases and colorectal cancer early diagnosis company Novel Diagnostics (Bergen, Norway) has appointed board member Guido Guidetti as president, in which role he will oversee international marketing, licensing and business development strategies. In 26 years in the industry, he has advised and offered consultancy to J&J, Abbott, International Murex Technologies (including on its purchase by Abbott), Chiron and Apogent Technologies, among others.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts